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Abstract
Background
A thorough analysis of continuous adventitious sounds (CAS) can provide distinct and com-
plementary information about bronchodilator response (BDR), beyond that provided by spi-
rometry. Nevertheless, previous approaches to CAS analysis were limited by certain
methodology issues. The aim of this study is to propose a new integrated approach to CAS
analysis that contributes to improving the assessment of BDR in clinical practice for asthma
patients.
Methods
Respiratory sounds and flow were recorded in 25 subjects, including 7 asthma patients with
positive BDR (BDR+), assessed by spirometry, 13 asthma patients with negative BDR
(BDR-), and 5 controls. A total of 5149 acoustic components were characterized using the
Hilbert spectrum, and used to train and validate a support vector machine classifier, which
distinguished acoustic components corresponding to CAS from those corresponding to
other sounds. Once the method was validated, BDR was assessed in all participants by
CAS analysis, and compared to BDR assessed by spirometry.
Results
BDR+ patients had a homogenous high change in the number of CAS after bronchodilation,
which agreed with the positive BDR by spirometry, indicating high reversibility of airway
obstruction. Nevertheless, we also found an appreciable change in the number of CAS in
many BDR- patients, revealing alterations in airway obstruction that were not detected by
spirometry. We propose a categorization for the change in the number of CAS, which
allowed us to stratify BDR- patients into three consistent groups. From the 13 BDR- patients,
6 had a high response, similar to BDR+ patients, 4 had a noteworthy medium response, and
1 had a low response.
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Conclusions
In this study, a new non-invasive and integrated approach to CAS analysis is proposed as a
high-sensitive tool for assessing BDR in terms of acoustic parameters which, together with
spirometry parameters, contribute to improving the stratification of BDR levels in patients
with obstructive pulmonary diseases.
Introduction
Asthma is a chronic respiratory disease characterized by airway inflammation and the result-
ing airway obstruction. The clinical features of asthma include variable respiratory symptoms,
such as wheezes, and variable airflow limitation [1]. Airflow limitation is commonly assessed
by spirometry. The most reliable parameters in spirometry are the forced expiratory volume in
1 second (FEV1) and its ratio to forced vital capacity (FVC). A reduced FEV1, when accompa-
nied by a decrease in the FEV1/FVC ratio below the normal range of values (0.75–0.8), is a
clear indicator of airway obstruction and airflow limitation [1].
When airway obstruction is confirmed from spirometry parameters, a bronchodilator
response (BDR) test is usually performed to measure variation in airflow limitation. The BDR
test consists of measuring the improvement in FEV1 within minutes after inhalation of a
short-acting beta2-agonist bronchodilator [2]. Bronchodilators cause the airway smooth mus-
cles to relax, which allows the airways to dilate, thus reducing airflow limitation. Obtaining evi-
dence of high variability in airflow limitation is one of the main components of asthma
diagnosis. Moreover, assessing BDR periodically after the initial diagnosis of asthma is an
essential part of asthma control, since uncontrolled asthma is associated with a greater BDR
than well-controlled asthma [1].
Despite the widespread use of the BDR test, the standard BDR criterion is still a subject of
controversy [3–5]. The percentage increase in FEV1 is highly influenced by the baseline FEV1
[1]. Subjects with a low baseline FEV1 are more likely to have a greater BDR than subjects with
a high baseline FEV1, who hardly ever have a positive BDR [6]. Therefore, a diagnosis of
asthma should not be made based only on spirometry parameters [2].
The assessment of respiratory symptoms is also a major component of asthma diagnosis
and control [1, 7]. Together with lung function, asthma symptoms should be assessed as often
as possible. The common procedures for assessing asthma symptoms include physical exami-
nation and direct questioning, and the most frequent finding is the presence of wheezes—the
most common type of continuous adventitious sounds (CAS)—on auscultation [1]. CAS are
musical sounds with a sinusoidal-like waveform and a duration of over 100 ms [8]. In particu-
lar, wheezes have a pitch between 100 Hz and 1000 Hz and are generated by oscillation of air-
way walls in narrowed airways, as in asthma. Besides wheezes, CAS include rhonchi, which are
similar to wheezes but coarser and lower in pitch (around 150 Hz), are often related to the
movement of air through secretions, and have a gurgling or snoring-like quality [8, 9]. How-
ever, the term rhonchi is often used to report low-pitched wheezes, and vice versa. In fact, the
difference between pure sinusoidal low-pitched wheezes and the more complex waveform of
rhonchi is a subject of controversy and there is still some discrepancy in the literature [9, 10].
Therefore, and since bronchodilators act on airway muscles, but not on secretions, this study
focuses only on CAS with a pitch above 200 Hz for assessing BDR [9, 11].
Conventional techniques to assess the presence of CAS, such as manual auscultation and
respiratory questionnaires, are highly dependent on the subjectivity of the physicians and
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patients involved. In this sense, the automatic analysis of CAS provides objective, quantita-
tive, and complementary information that may contribute to improving the assessment of
asthma.
The association between CAS, airway obstruction severity, and BDR has been reported in
several previous studies using conventional techniques [11–15]. On the other hand, the auto-
matic detection and analysis of CAS has increased the objectivity of auscultation. Early studies
used the power spectrum for analyzing CAS patterns [16, 17], quantifying the number of CAS
[18, 19], or estimating the duration and frequency parameters of CAS [20–23]. More recently,
time-frequency analysis has been used to calculate CAS features more precisely than with the
power spectrum [24–28]. Some CAS features have been related to airway obstruction severity
and BDR in patients with obstructive pulmonary diseases [19, 20, 22, 23, 29–31].
The lack of a standard method for CAS recording and analysis has led to several different
CAS analysis approaches, with some methodological issues that could limit the potential of
CAS analysis in clinical practice. Typically, respiratory sound signals have been recorded either
at maintained flow levels or during forced expiratory maneuvers. However, CAS only appear
above a critical flow, which depends on several factors and varies between people [32]. There-
fore, as we previously described [33], CAS may be present over a wide range of flow levels. Fur-
thermore, using only one microphone placed over the trachea, as in [17, 22, 29–31], could lead
to a failure to detect changes in the structure of smaller airways after treatment.
Spectrogram, which has been the most widely used technique for CAS analysis, has poor
resolution and could lead to an underestimation of CAS, as we demonstrated in a previous
work [34]. Further, the intensity of CAS has rarely been analyzed, unlike their duration and
frequency. Moreover, other CAS analysis methods have been applied to datasets in which
background noises and artefacts had been manually rejected beforehand. Therefore, there is a
lack of robust methodology in the analysis of CAS that can be directly applied to recorded
respiratory sound signals. To date, an approach that considers all these aspects of CAS analysis
has not been proposed.
In this study, we propose an integrated approach to CAS analysis for the assessment of
BDR in asthma patients. This new approach includes a multichannel recording of respiratory
sounds using four contact microphones and a progressive respiratory maneuver with variable
flow that enables the analysis of CAS at several flow levels. This approach also includes our
recently proposed method for CAS segmentation, based on the Hilbert spectrum [34], which
allows CAS to be fully characterized with regard to duration, mean frequency, and intensity.
Furthermore, we analyze CAS directly from the recorded signals, without the prior removal of
other sounds and noises. Accordingly, we trained and validated a high performance classifier
to retain only CAS and avoid the analysis of other sounds.
The proposed novel and robust approach to CAS analysis has been applied to asthma
patients in order to assess BDR in terms of acoustic parameters. We suggest that this approach
to CAS analysis provides distinct and complementary information about BDR, beyond that
provided by spirometry, and could contribute to improving the stratification of BDR in asthma
patients.
Materials and methods
Ethics statement
The study was conducted in the Respiratory Function Laboratory at Germans Trias i Pujol
University Hospital and approved by the Human Research Ethics Committee of the hospital.
All participants gave written informed consent, following the World Medical Association’s
Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects.
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Study population
Asthma patients who came to the Pulmonology Service at Germans Trias i Pujol University
Hospital, from March 2011 to May 2015, for regular examinations were recruited for perform-
ing the BDR test and participating in the respiratory sound recording and analysis study.
BDR was measured by spirometry and respiratory sounds were recorded, before and after
bronchodilator administration, in 54 asthma patients. The patients were asked to withhold any
bronchodilator medication overnight (at least twelve hours) prior to testing [1]. An increase in
FEV1 of>12% and>200 mL from the baseline was considered to be a positive BDR (BDR+)
[1], otherwise it was considered to be a negative BDR (BDR-). From the 54 recruited patients
(17 BDR+ and 37 BDR-), 37 patients (15 BDR+ and 22 BDR-) who had baseline FEV1<80%—
that is, a risk factor for asthma exacerbations [1]—were considered eligible for the CAS analy-
sis study.
Since this study focuses on CAS analysis, and CAS are not present in all asthma patients [1],
the respiratory sound signals of the 37 eligible patients were audiovisually inspected to distin-
guish between patients with and without CAS, at least at one of the recorded respiratory sound
channels, and either at baseline or after bronchodilator administration. Due to the difficulty in
determining the true pitch of CAS by audiovisual inspection of respiratory sound signals, no
limit was considered for the pitch of CAS in this stage of the study. From the 37 eligible
patients, 20 had presence of CAS (7 BDR+ and 13 BDR-) and were included in the CAS analy-
sis study.
In addition, 5 control participants were recruited from healthy subjects who had never been
diagnosed with any chronic respiratory disease and had normal baseline FEV1.
Respiratory sound and flow recording protocol
Four piezoelectric contact microphones were used for recording respiratory sounds (TSD108,
Biopac1). Microphones were placed on the surface of the subjects’ backs, at the base and near
the upper lobe of the two lungs (Fig 1). Respiratory flow was recorded simultaneously with
respiratory sounds, using a pneumotachograph (TSD107B, Biopac1). All signals were sampled
at 12500 samples/s (MP150, Biopac1) and, after digitalization, the respiratory sound signals
were band-pass filtered between 70 Hz and 2000 Hz.
Respiratory sound signals from the back are affected by the low-pass filtering effect of the
chest [35], and wheezes barely appear at frequencies above 1600 Hz [36]. Accordingly, respira-
tory sound signals were decimated by four to a sampling rate of 3125 Hz.
The subjects were placed in a sitting position and performed six progressive maneuvers
with variable flow, three pre-bronchodilator and three post-bronchodilator. They were guided
by a video that showed a sequence of arrows spreading out, either upwards (inspiration) and
downwards (expiration). The duration and length of the arrows determined the rate and depth
of breathing and these varied over the course of each maneuver, thus encouraging subjects to
start breathing normally, becoming progressively faster and deeper until they reached the
deepest breaths they were able to take, and finally returning to normal breathing. Around
twenty respiratory cycles were obtained from each progressive maneuver.
Respiratory sound and flow signal processing
Segmentation of respiratory phases and definition of flow quartiles. The respiratory
phases were segmented by means of a zero-crossing detector applied to the flow signals, as
described in our previous work [37]. After segmenting the respiratory phases from a subject’s
three pre-bronchodilator and three post-bronchodilator flow signals, the inspiratory and expi-
ratory flow ranges were calculated as the differences between the maximum and minimum
Respiratory sound analysis for the assessment of bronchodilator response
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peak flows of all the inspiratory and expiratory phases, respectively. Flow ranges were divided
into four quartiles, Q1-Q4, with Q1 including the lowest flows. In this way, a flow quartile was
assigned to each respiratory phase, according to its peak flow (Fig 2).
Acoustic component segmentation and characterization. After having segmented all
the respiratory phases, the corresponding respiratory sound signals from the four recorded
channels of a subject were analyzed, for acoustic component segmentation, using a new
Fig 1. Flow chart of the proposed respiratory sound recording and CAS analysis approach. BD,
bronchodilator; CAS, continuous adventitious sounds; Q1-Q4, flow quartiles; RS, respiratory sounds; ΔCASGlob,
change in the number of CAS after bronchodilation.
doi:10.1371/journal.pone.0171455.g001
Fig 2. Respiratory sounds and flows recorded during the performance of a progressive maneuver at baseline. Segmented
respiratory phases are highlighted in black (inspiration) and dark grey (expiration). Q1-Q4 labels indicate the flow quartile assigned to
each respiratory phase.
doi:10.1371/journal.pone.0171455.g002
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method that we have recently described in two previous studies, based on the analysis of the
instantaneous frequency (IF) and envelope (IE) sequences [33], and the Hilbert spectrum
time-frequency distribution [34]. The method is briefly described in this section.
First, our automatic CAS detection algorithm [33] was applied to each respiratory sound
signal. Based on the fact that the IF dispersion markedly decreases when CAS appear within a
respiratory sound signal, that algorithm detected respiratory sound signal segments that were
more likely to contain CAS. To do that, each respiratory sound signal was decomposed by
ensemble empirical mode decomposition into a set of narrowband components for which the
IF and IE sequences were calculated by means of the Hilbert transform. Then, a number of dis-
persion-based criteria were used on the IF sequences to detect respiratory sound signal seg-
ments with a lower IF dispersion. Each detected segment was characterized by means of a set
of features extracted from the IF and IE sequences, including the mean and standard deviation
IF. These features were used to classify respiratory sound signal segments as CAS segments or
normal segments, using a support vector machine classifier.
After detecting CAS and normal segments within a respiratory sound signal, the acoustic
component segmentation was performed [34]. First, the IF and IE sequences were rearranged
into an array to obtain the Hilbert spectrum time-frequency distribution. Then, the previously
calculated mean and standard deviation IF of each detected segment were used to mark out an
analysis area in the Hilbert spectrum. Each analysis area was centred on the mean IF, had a fre-
quency width of twice the standard deviation IF, and had the same duration as its correspond-
ing segment. Analysis areas corresponding to CAS segments (CAS areas) were more likely to
contain acoustic components corresponding to CAS (CAS components), whereas analysis
areas corresponding to normal segments (normal areas) were more likely to contain acoustic
components corresponding to other sounds (non-CAS components) (Fig 3). In any case, since
CAS appeared in the Hilbert spectrum as thin ridges where CAS energy concentrated (Fig 3),
any acoustic components represented as ridges were automatically segmented using a region-
growing algorithm and region-linking criteria. Both normal and CAS areas were considered
for seed point searching and local region growing, but different region-linking criteria were
used, depending on the type of analysis area, to guarantee the temporal and frequency continu-
ity of the segmented acoustic components.
In respiratory cycles containing multiple CAS components, either occurring at different
times (multiple monophonic CAS) or overlapping in time (polyphonic CAS), each CAS com-
ponent appeared in a different analysis area and was segmented separately (Fig 3A, 3C and
3D). Therefore, multiple monophonic CAS or polyphonic CAS counted as two (or more) CAS
components.
Our algorithm calculated a number of parameters for each segmented acoustic component.
Duration (D) was calculated as the difference between the highest and the lowest time index
among all the points belonging to the segmented acoustic component. Intensity (I) was calcu-
lated as in Eq 1.
IðdBÞ ¼ 10log10
X
ðt;f Þ2ridge
Hðt; f Þ2
X
ðt;f Þ=2ridge
Hðt; f Þ2
ð1Þ
where H(t,f) is the Hilbert spectrum, t is the time index, f is the frequency index, (t,f)2ridge are
points of H(t,f) that are inside the segmented acoustic component, and (t,f)=2ridge are points of
H(t,f) that are outside the segmented acoustic component.
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Some frequency parameters, including the mean frequency (FMean) and the standard devia-
tion frequency (σF), were calculated as in Eqs 2 and 3.
FMeanðHzÞ ¼
X
ðt;f Þ2ridge
fHðt; f Þ
X
ðt;f Þ2ridge
Hðt; f Þ
ð2Þ
sFðHzÞ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiX
ðt;f Þ2ridge
ðf   FmeanÞ
2Hðt; f Þ
X
ðt;f Þ2ridge
Hðt; f Þ
v
u
u
u
u
t ð3Þ
Fig 3. Segmentation of acoustic components from the Hilbert spectrum. For each subfigure: flow and respiratory sound signals
of a respiratory cycle (top), the Hilbert spectrum of the respiratory sound signal (middle), and the acoustic components segmented
using our acoustic component segmentation method [34] (bottom). In the Hilbert spectrums, CAS areas are plotted in green, and
normal areas are plotted in red. A) Two inspiratory CAS components occurring at different times (multiple monophonic CAS). B) A
single expiratory CAS component. C) D) Inspiratory CAS components overlapping in time (polyphonic CAS). Subfigures B, C, and D
also show some low-pitched non-CAS components that correspond to normal respiratory sounds but are similar to CAS components,
and therefore are segmented by our acoustic component segmentation method.
doi:10.1371/journal.pone.0171455.g003
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Moreover, the mean point-by-point σF (sF ) was calculated as the average value of the standard
deviation frequency at each time index along the segmented acoustic component.
According to the definition of CAS [8], only acoustic components with D>100 ms were
retained, regardless of their FMean, as described in [34].
Classification of acoustic components
Besides CAS components, non-CAS components corresponding to other sounds, such as nor-
mal respiratory sounds (Fig 3B, 3C and 3D) or background noises from the clinical environ-
ment (Fig 4), often appear in the Hilbert spectrum as ridges similar to those described by CAS.
These non-CAS components could be segmented by our acoustic component segmentation
method, thus resulting in an overestimation of the presence of CAS components.
In this study, a support vector machine classifier [38, 39] has been trained and validated in
order to distinguish CAS components from non-CAS components. This classifier is the last
Fig 4. Background noises from the clinical environment. Four examples of respiratory cycles containing background noises,
including talking (A), footsteps (B), banging (C), and furniture dragging (D), from the clinical environment. These sounds appear in the
Hilbert spectrum as high-pitched (above 200 Hz) acoustic components with a certain degree of temporal and frequency continuity,
similar to CAS components.
doi:10.1371/journal.pone.0171455.g004
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stage of our proposed integrated approach to CAS analysis, and complements our acoustic
component segmentation method [33, 34].
In order to form the training and testing datasets for the classifier, our acoustic component
segmentation method was applied to the respiratory sound signals from the four recorded
channels of the twenty-five subjects. For each subject, the channel with the highest number of
segmented acoustic components, during the pre-bronchodilator and post-bronchodilator pro-
gressive maneuvers, was selected.
A total of 5149 acoustic components were obtained from the selected channels of the study
subjects and formed the classification dataset. These acoustic components were labeled as CAS
components (816 components) or non-CAS components (4333 components) by audiovisual
inspection of the corresponding respiratory sound signals. Input feature vectors included the
essential features of CAS (D, FMean, and I), σF, sF , and the type of analysis area (Fig 5). These
parameters were calculated by our acoustic component segmentation method [34] and have
been described in the previous section.
CAS components had lower σF and sF than non-CAS components (Fig 5C and 5D).
These two parameters represent the degree of energy dispersion of the acoustic components
in the Hilbert spectrum. As described in the previous section, CAS have a sinusoidal-like
waveform, and therefore their energy is more concentrated (lower σF and lower sF ) around
the FMean than the energy of non-CAS components, which is more scattered (higher σF and
Fig 5. Features of the classification dataset. In all subfigures, each circle represents an acoustic component of
the classification dataset. Subfigures A and B show the duration (D), mean frequency (FMean), and intensity (I) of
CAS and non-CAS components, respectively. Subfigures C and D show the standard deviation frequency (σF),
mean point-by-point σF (sF ), and type of analysis area of CAS and non-CAS components, respectively.
doi:10.1371/journal.pone.0171455.g005
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higher sF ). Moreover, CAS components were more likely to be segmented from CAS areas
(Fig 5C) than non-CAS components, most of which were segmented from normal areas
(Fig 5D).
The imbalance between the number of CAS components (16% of the classification dataset)
and non-CAS components (84% of the classification dataset) represents the normal situation
in respiratory sound analysis. The sources of this imbalance were normal respiratory sounds
and background noises. Different from CAS, which do not appear in all respiratory cycles,
normal respiratory sounds are always present in respiratory sound signals. These sounds have
a frequency band from around 70 Hz up to 200–250 Hz [8, 35]. Since our acoustic component
segmentation method did not set any limit for the FMean of the acoustic components, 3670
non-CAS components (71% of the classification dataset) with FMean<200 Hz (Fig 5B) were
mainly segmented from normal respiratory sounds, as those shown in Figs 3B–3D and 4A.
These non-CAS components had lower I than low-pitched CAS components (Fig 5A). On the
other hand, respiratory sound signals were recorded in a room next door to the lung function
laboratory and the clinic’s waiting room at the Germans Trias i Pujol Hospital. Even though
the room was quiet, many noises from outside the room, mainly including those shown in Fig
4, were easily listened to and often appeared in the recorded respiratory sound signals. This is
evidenced in Fig 5B, which shows 663 non-CAS components (13% of the classification dataset)
corresponding to background noises with low D (mostly below 0.3 s), high FMean (above 200
Hz), and much lower I than CAS components.
The dataset was randomly partitioned into training (65%, 3349 components) and testing
(35%, 1800 components) subsets, each one containing a proportionate share of the CAS and
non-CAS components from each subject. The training subset was used to find the optimum
parameters of the classifier. In binary classification, the goal of a support vector machine classi-
fier is to find the optimal hyperplane that separates all data points into two classes. However, a
simple hyperplane cannot be found in the original feature space when the relation between
classification labels and input features is nonlinear. In that case, a nonlinear kernel function is
used to map input features into a higher dimensional space, where linear classification can be
performed. As a rule of thumb [39], if the number of input features is large there is no need to
map data to a higher dimensional space. On the contrary, if the number of features is small
and much lower than the number of instances in the classification dataset, using a nonlinear
kernel improves the performance of the classifier. Since, in this study, feature vectors had 6
components and the training subset had 3349 acoustic components, a nonlinear radial basis
function kernel was used to train the classifier. The radial basis function is the most commonly
used kernel among nonlinear kernels, since it has high performance in many classification
problems and has less parameters than the polynomial kernel, which facilitates the identifica-
tion of the optimum parameters [38].
Using a radial basis function kernel required identifying two parameters: the penalty
parameter, C, and the kernel scale, σ. The standard grid-search method with cross-validation
was used to identify the optimum parameters [38]. Several combinations of exponentially
growing sequences of C (e-2, e-1.75, e-1.5, . . ., e6) and σ (e-0.5, e-0.25, e0, . . ., e3.5) were used as ini-
tial points for finding local minimums of the 10-fold cross-validation loss function. Each (C, σ)
pair which produced a local minimum was used to train a support vector machine classifier
from the training subset. The resulting classifiers were validated using the testing subset and
their performance was evaluated in terms of accuracy, sensitivity, specificity, and positive pre-
dictive value.
The training and validation steps for all the (C, σ) pairs were repeated for one hundred dif-
ferent random dataset partitions, so that the results were independent of the initial partition.
For each (C, σ) pair, the mean and standard deviation of the performance parameters along all
Respiratory sound analysis for the assessment of bronchodilator response
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partitions were calculated. Since the number of CAS components in the dataset was much
lower than the number of non-CAS components, sensitivity and positive predictive value in
detecting CAS components were the parameters used for selecting the optimum (C, σ) pair.
Accordingly, the (C, σ) pair that achieved the highest summation of the mean testing sensitivity
and positive predictive value was selected. Finally, the support vector machine classifier that
was trained with the selected (C, σ) pair, and reached the highest summation of the testing sen-
sitivity and positive predictive value, among all partitions, was chosen to distinguish CAS com-
ponents from non-CAS components.
Channel selection and CAS component analysis
The acoustic component classifier was applied to all acoustic components segmented from the
four recorded channels of the twenty-five subjects. As mentioned in the introduction, most
low-pitched CAS are related to secretions and are not affected by bronchodilators, so they
should not be considered for BDR assessment. Accordingly, in this study, all CAS components
with FMean<200 Hz were automatically rejected. This cut-off has been widely described in the
literature [11, 35, 40, 41] and has been recently recommended by the task force for lung sounds
from the European Respiratory Society [9, 10]. Nevertheless, the frequency cut-off for distin-
guishing low-pitched CAS from high-pitched CAS is still a source of debate.
For each recorded channel of a subject, the number of inspiratory or expiratory CAS, either
pre-bronchodilator or post-bronchodilator, was expressed as in Eq 4.
#CASXið%Þ ¼ 100 
#CAS componentsXi
#Respiratory cyclesXi
i ¼ 1; 2; 3; 4 X ¼ fInsPre   BD; InsPost  
BD;ExpPre   BD;ExpPost   BDg
ð4Þ
where the # symbol denotes “number of”. Respiratory cycles containing multiple monophonic
CAS or polyphonic CAS contributed more than one CAS component to the number of CAS.
Moreover, the change in the number of CAS after bronchodilator administration was calcu-
lated as in Eqs 5 and 6.
DCASInsð%Þ ¼ j#CASInsPost  BD   #CASInsPre  BDj
DCASExpð%Þ ¼ j#CASExpPost  BD   #CASExpPre  BDj
DCASGlobð%Þ ¼ j#CASGlobPost  BD   #CASGlobPre  BDj ¼ maxfDCASIns;DCASExpg ð5Þ
nDCASGlobð%Þ ¼ 100 
DCASGlob
#CASGlobPre  BD
ð6Þ
ΔCASGlob and nΔCASGlob are two ways of expressing the change in the number of CAS.
ΔCASGlob is simply the absolute value of the difference between the number of CAS post-bron-
chodilator and the number of CAS pre-bronchodilator, whereas in nΔCASGlob that difference
is normalized and expressed as a percentage of the number of CAS pre-bronchodilator. For
each subject, the channel with the highest ΔCASGlob was selected to assess BDR in terms of
number of CAS. Besides the number of CAS, we also analyzed the FMean, D, and I of CAS com-
ponents, since these parameters could be different between the two groups of asthma patients
and could vary after bronchodilator administration.
Respiratory sound analysis for the assessment of bronchodilator response
PLOS ONE | DOI:10.1371/journal.pone.0171455 February 8, 2017 11 / 23
Statistical analysis
Statistical analyses were performed using the Statistics and Machine Learning Toolbox™ in
Matlab1 R2014a.
Differences in the anthropometric and spirometry variables of the three groups of subjects
(controls, BDR- patients, and BDR+ patients) were analyzed using non-parametric Kruskal-
Wallis tests. For those variables showing a significant difference (p<0.05), multiple post hoc
group comparisons were performed, using the Bonferroni adjustment, to determine where the
difference between the three groups was.
The change in the number of CAS of the study subjects was analyzed in two ways. First, dif-
ferences between #CASGlobPre-BD and #CASGlobPost-BD were analyzed separately for each group
of subjects, using nonparametric Wilcoxon rank sum tests, since the number of subjects within
each group was not large enough to test normality and use a parametric test. Second, a Wil-
coxon rank sum test was also used to analyze the difference in nΔCASGlob between BDR
+ patients and BDR- patients. More details about statistical analyses of the number of CAS and
CAS features are provided later in the text.
Results and discussion
Study subjects
Anthropometric and spirometry data of the twenty-five study subjects are shown in Table 1.
The subjects did not differ significantly in age or body mass index. There was a significant
difference between the height of controls and the height of BDR+ patients. Although lung
function is affected by height, which is a determinant of lung size and airway dimension [42,
43], expressing FEV1 and FVC as percentages of predicted values eliminates the influence of
Table 1. Anthropometric and spirometry data of the study subjects.
Variables Controls BDR- patients BDR+ patients p-value
Anthropometric data
Total number 5 13 7
Gender (male:female) 3:2 5:8 3:4
Age (years) 31 (26–50) 53 (37–64) 42 (34–66) 0.359
Height (m) 1.74 (1.70–1.82)† 1.67 (1.62–1.71) 1.62 (1.54–1.66)† 0.03
BMI (kg/m2) 23.5 (20.48–26.66) 25.15 (21.73–29.43) 22.22 (20.25–25.6) 0.463
Spirometry data
FEV1 (% of predicted) 97 (90–99)*† 72 (64–75)* 51 (42–60)† 0.00018
ΔFEV1 (% from baseline) 1 (0–2)† 8 (6–12)§ 41 (26–51)†§ <0.0001
ΔFEV1 (% of predicted) 1 (0–2)† 6 (4–8)§ 19 (15–25)†§ <0.0001
FVC (% of predicted) 97 (92–104)† 73 (68–88) 62 (61–77)† 0.008
ΔFVC (% from baseline) -3 (-4–-1.5)† 3 (2–9)§ 21 (14–36)†§ 0.00015
FEV1/FVC pre-BD (%) 80 (75–84)† 69 (63–76) 55 (52–63)† 0.002
FEV1/FVC post-BD (%) 83 (78–86)† 72 (65–81) 68 (60–72)† 0.031
p-values were calculated using non-parametric Kruskal-Wallis tests. Multiple post hoc comparison tests were performed using the Bonferroni adjustment.
* Difference between controls and BDR- patients (p<0.05)
† Difference between controls and BDR+ patients (p<0.05)
§ Difference between BDR- and BDR+ patients (p<0.05)
BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; BD, bronchodilator; BDR-/+, negative/positive
bronchodilator response. All values are presented as median (interquartile range).
doi:10.1371/journal.pone.0171455.t001
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height. Predicted values are calculated using reference equations that are a function of sex, age,
and height and are derived from large healthy populations [2]. However, the standard BDR
criterion, based on the percentage change in FEV1 from baseline, is dependent on the baseline
FEV1, and therefore on height. For this reason, the use of a BDR criterion based on the per-
centage of predicted FEV1 was proposed by the European Respiratory Society [44], and sup-
ported in some previous studies [42, 43, 45]. When expressed as a percentage of predicted
FEV1, a change that is>9% is considered to be a positive BDR. In this study, changes in FEV1
of the three groups of subjects did not differ for the two BDR criteria, as shown in Table 1.
As expected, there were significant differences in all the spirometry parameters between
controls and BDR+ patients, with the latter having lower baseline FEV1, FVC, and FEV1/FVC
values and higher changes in all these parameters after bronchodilation. Regarding BDR-
patients, there were no significant differences in baseline FVC and baseline FEV1/FVC
between them and either controls or BDR+ patients. Furthermore, although baseline FEV1
was significantly lower in BDR- patients than in controls, there were no significant differences
in the change in FEV1 between the two groups. However, the change in FEV1 was significantly
lower in BDR- patients than in BDR+ patients. These results show that BDR- patients are of
special clinical interest since, although their baseline spirometry parameters may range from
those of controls to those of BDR+ patients, their lung function does not significantly change
after bronchodilation. In this group, the analysis of CAS before and after bronchodilator
administration could provide useful complementary information about BDR, from the point
of view of pulmonary acoustics.
Classification of acoustic components
The (C, σ) pair with the highest summation of the mean testing sensitivity (85.9% ± 1.6%) and
positive predictive value (88.9% ± 1.8%) for all dataset partitions was the (1.92104, 12.66) pair.
Among the support vector machine classifiers trained with these optimum parameters and the
different dataset partitions, we selected the classifier that achieved the highest summation of
the testing sensitivity (87.7%) and positive predictive value (92.2%). As shown in Table 2, the
selected support vector machine classifier achieved high performance parameters for differen-
tiating CAS components from non-CAS components.
Table 2 also shows the performance of the acoustic component classifier only for compo-
nents with FMean>200 Hz, which are the acoustic components considered for BDR assessment
in this study. Although in this case the performance of the classifier was slightly lower than
Table 2. Performance of the acoustic component classifier.
All components Components with FMean>200 Hz
Testing Overall Overall
True positive 249 719 370
True negative 1495 4260 620
False positive 21 73 43
False negative 35 97 65
Sensitivity (%) 87.7 88.1 85.1
Specificity (%) 98.6 98.3 93.5
Positive predictive value (%) 92.2 90.8 89.6
Accuracy (%) 96.9 96.7 90.2
True positive/negative, CAS/non-CAS components properly classified; False positive/negative, non-CAS/CAS components misclassified; FMean, Mean
frequency.
doi:10.1371/journal.pone.0171455.t002
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that for all acoustic components, it was still high. It is important to note that the classification
dataset of this study included respiratory sound signals in which background noises and arte-
facts were not rejected beforehand, that is just like they were recorded in a clinical environ-
ment. Moreover, as described in [34], our acoustic component segmentation method is less
dependent on amplitude criteria than most previous algorithms for CAS detection. Therefore,
our method allowed us to detect CAS components with widely different intensities, including
many weak CAS components, whereas previous algorithms for CAS detection focused on CAS
components with higher intensity. In this sense, the 435 CAS components with FMean>200 Hz
included in our classification dataset had intensities between -18.1 and 16.9 dB (-2 dB ± 5.7
dB). From these CAS components, the 65 false negatives corresponded to weak CAS compo-
nents, with a very low intensity of -10 dB ± 3.6 dB. Even so, our classifier managed to detect
not only loud CAS components, but also many CAS components with low intensity.
Analysis of the number of CAS to assess BDR
After segmenting and classifying the acoustic components from the four recorded channels of
the study subjects, the channel with the highest ΔCASGlob was selected for each subject. The
channel selection for the 20 asthma patients was the following: lower left in 7 patients, lower
right in 3 patients, upper left in 7 patients, and upper right in 3 patients. Moreover, 15 of the
20 asthma patients had the highest ΔCASGlob in the inspiratory phase, whereas 5 asthma
patients had the highest ΔCASGlob in the expiratory phase. These results reflect the diffusion
and non-uniform distribution of airway obstruction in asthma. Since CAS are associated with
airway obstruction, these may appear at any point throughout the lungs, from central to
peripheral airways, and during inspiration, expiration, or both [46].
A key point of our proposed approach to CAS analysis is the progressive respiratory
maneuver with variable flow. This is a real advantage as compared to previous studies, in
which CAS were analyzed at constant flows or during forced expiratory maneuvers. It has
been reported that forced expiratory wheezes have low specificity for the clinical diagnosis of
asthma, since many wheezes may also appear in healthy people during forced expiratory
maneuvers [12, 18]. On the other hand, a flow-dependent analysis of CAS is important because
CAS only appear above a critical flow, and this depends on the mechanical properties of air-
ways, which in turn vary between people [32]. In this sense, the progressive respiratory maneu-
ver, which is easier to perform than the forced expiratory maneuver, allows CAS to be
analyzed at a wide range of flow levels, from normal to forced breathing.
Fig 6 shows #CASGlobPre-BD and #CASGlobPost-BD for the flow quartiles and the total flow
range of the three groups of subjects.
As expected, the number of CAS increased with flow in both BDR- and BDR+ patients,
indicating that the greater the flow the higher the possibility of CAS appearing (Fig 6B and
6C). Even so, CAS appeared over the wide range of flow levels.
In controls, #CASGlobPre-BD and #CASGlobPost-BD were nearly zero, which agreed with the
absence of airway obstruction in these subjects. However, in both BDR- and BDR+ patients,
#CASGlobPre-BD was appreciable, suggesting some degree of airway obstruction. In BDR
+ patients, #CASGlobPost-BD was not only significantly lower than #CASGlobPre-BD, but nearly
zero, which means that CAS almost completely disappeared (Fig 6C). Therefore, BDR
+ patients also had a high BDR in terms of number of CAS. Nevertheless, in BDR- patients,
#CASGlobPost-BD was significantly lower than #CASGlobPre-BD (Fig 6B) but still appreciable, indi-
cating some degree of airway obstruction reversibility, but lower than that of BDR+ patients.
Due to the high degree of inter-subject variability in #CASGlobPre-BD, and therefore in ΔCAS-
Glob, these parameters were analyzed separately for each subject (Fig 7).
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Only subjects with #CASGlobPre-BD>5% were considered for CAS analysis, as indicated in
Fig 7A (red dashed line). Two aspects were taken into consideration to fix this threshold. First,
around 10% of detected CAS were false positives (see positive predictive value in Table 2). Fur-
ther, as shown in Fig 6B and 6C, #CASGlobPre-BD in the total flow range was mostly below 50%
in asthma patients. Therefore, the proportion of #CASGlobPre-BD that corresponded to false CAS
was around 5%. False CAS were not affected by bronchodilators, and therefore should not be
considered for BDR assessment. Second, Fig 7A shows that all controls, who were healthy sub-
jects and were not expected to have CAS, had #CASGlobPre-BD<3%. Assuming that value as the
normal #CASGlobPre-BD in healthy people, we considered 5% to be an appropriate lower limit
for #CASGlobPre-BD, so that it was indicative of some degree of airway obstruction. Moreover,
this threshold prevented nΔCASGlob from taking meaningless values due to very low
Fig 7. Individual change in the number of CAS after bronchodilator administration. A) Number of CAS at baseline
(#CASGlobPre-BD) and change in the number of CAS (ΔCASGlob) of each study subject. The dashed line is the line of equality
(ΔCASGlob = #CASGlobPre-BD). That is, points on the line corresponded to subjects whose CAS completely disappeared after
bronchodilation. Points under the line corresponded to subjects whose number of CAS was partially reduced after bronchodilation.
Points above the line corresponded to subjects whose number of CAS increased after bronchodilation. B) ΔFEV1 and nΔCASGlob of
BDR- patients whose #CASGlobPre-BD was >5% (white points to the right of the red dashed line in A). Points in A and B corresponding
to the same subject have been labelled with the same Roman numeral. As in A, the dashed line in B represents ΔCASGlob =
#CASGlobPre-BD, which means nΔCASGlob = 100% (see Eq 6). Pink area: 0%<nΔCASGlob<33%, purple area: 33%<nΔCASGlob<66%,
blue area: 66%<nΔCASGlob.
doi:10.1371/journal.pone.0171455.g007
Fig 6. Number of CAS of the three groups of subjects. Box plot distributions of the number of CAS at baseline (#CASGlobPre-BD)
and after bronchodilator administration (#CASGlobPost-BD) for the flow quartiles (Q1-Q4) and the total flow range of controls (A), BDR-
patients (B), and BDR+ patients (C). Circles within boxes = medians, boxes = interquartile ranges. Comparisons between
#CASGlobPre-BD and #CASGlobPost-BD in the total flow range of BDR- and BDR+ groups were made using Wilcoxon rank sum tests.
Significant differences (p<0.05) are indicated with an asterisk.
doi:10.1371/journal.pone.0171455.g006
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#CASGlobPre-BD values. Taking into consideration this criterion, all controls, 2 BDR- patients,
and 2 BDR+ patients were not included in the CAS analysis (Fig 7A). Therefore, a total of 11
BDR- patients and 5 BDR+ patients were considered for the CAS analysis.
There was high variability in #CASGlobPre-BD and ΔCASGlob among asthma patients (Fig 7A).
Even so, all BDR+ patients were consistently close to the line of equality (ΔCASGlob = #CAS-
GlobPre-BD) which, according to Eq 5, means that #CASGlobPost-BD was nearly zero in all these
patients. However, BDR- patients exhibited varied responses in terms of number of CAS. The
variability in responses from BDR- patients is better shown in Fig 7B. In this case, nΔCASGlob
is used to counterbalance the high intersubject variability of #CASGlobPre-BD. Although all these
patients had a non-significant BDR in FEV1 (ΔFEV112%), they showed a wide range of
responses in the number of CAS, as expressed by nΔCASGlob. Instead of fixing a cut-off for
nΔCASGlob, we propose the following categorization: low response (L1, 0%nΔCASGlob33%),
medium response (L2, 33%<nΔCASGlob66%), and high response (L3, 66%<nΔCASGlob).
According to this categorization, 6 BDR- patients had high response, 4 BDR- patients had
medium response, and 1 BDR- patient had low response in nΔCASGlob.
The population nΔCASGlob is shown in Fig 8, for both BDR+ and BDR- patients, as well as
for the three subgroups of BDR- patients.
The difference in nΔCASGlob between BDR+ patients and BDR- patients was analyzed using
the Wilcoxon rank sum test, since the number of subjects within each group (5 BDR+ and 11
BDR- patients) was not large enough to use a parametric test. Due to the high variability of the
BDR- group, the difference in nΔCASGlob between the two groups was not significant
(p = 0.2614). Differences in nΔCASGlob between BDR+ patients and the three subgroups of
BDR- patients were analyzed using a Kruskal-Wallis test (p = 0.0223). Although the p-value
indicated a significant difference between the four groups, subsequent post hoc comparisons
did not detect significant differences between pairs of groups, presumably due to the small
Fig 8. Population change in the number of CAS after bronchodilator administration. Boxplot
distribution of the population change in the number of CAS. Circles within boxes = medians,
boxes = interquartile ranges, whiskers = 1.5*interquartile ranges. Pink area = low response (L1), purple
area = medium response (L2), blue area = high response (L3).
doi:10.1371/journal.pone.0171455.g008
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number of subjects per group (5 BDR+, 6 BDR- L3, 4 BDR- L2, and 1 BDR- L1). In any case,
two aspects should be noted. First, BDR+ patients had a homogenous high response in nΔCAS-
Glob, which agreed with the positive BDR in FEV1, indicating high reversibility of airway
obstruction. Second, the proposed categorization for nΔCASGlob allowed us to stratify BDR-
patients into smaller and more consistent groups of response in terms of number of CAS.
From the 11 BDR- patients, 6 (55%) had a high response in nΔCASGlob, similar to BDR
+ patients, whereas another 4 (36%) had a noteworthy medium response in nΔCASGlob.
It is true that the prevalence of significant (high or medium) responses in nΔCASGlob might
be favored by the fact that only patients who had CAS were included in this study, and bron-
chodilators are expected to reduce the number of CAS. However, CAS are not present in all
asthma patients. In fact, only 11 of the 22 BDR- patients who had FEV1<80% (see Study popu-
lation in the Materials and Methods section) had #CASGlobPre-BD>5% and were considered for
CAS analysis. Despite that, the 10 BDR- patients who had a medium or a high response in
nΔCASGlob still represent a noteworthy share (45%) of the initial 22 BDR- patients.
The aforementioned results indicate that the proposed approach to CAS analysis is a very
sensitive tool and provides useful information on BDR that is not provided by spirometry. Bron-
chodilators cause the airway muscles to relax, thus dilating and opening airways. The resulting
bronchodilation reduces airway obstruction and helps to relieve difficult breathing and symp-
toms, such as CAS. These bronchodilator effects were evident in BDR+ patients, as measured
not only by spirometry, which is the standard methodology for assessing BDR, but also by CAS
analysis. However, BDR- patients did not show a significant BDR in terms of spirometry param-
eters. It is noteworthy that spirometry yields global measurements of pulmonary ventilation and
may not be affected by local airway obstruction. In this regard, our proposed configuration for
recording respiratory sounds using four contact microphones (posterior base and posterior
upper lobe of the lungs) is a key point of the proposed approach to CAS analysis, since it pro-
vides a broader perspective of airway obstruction and allows us to detect local changes due to
bronchodilator administration. In fact, we found an appreciable response, in terms of number
of CAS, in most BDR- patients. The proposed multichannel configuration meets the CORSA
guidelines [47] and includes the minimum number of sensors required for analyzing the distri-
bution of CAS on the chest surface both laterally and vertically, without requiring a large num-
ber of sensors and the resulting larger amount of data. Indeed, in the literature, most studies
have focused on some or all of the proposed four lung regions [16, 20, 21, 27].
It should also be noted that asthma symptoms, such as CAS, may not necessarily correlate
with lung function [1, 7], but they provide different information about the disease state. It has
been reported that most asthma patients are not able to precisely correlate their respiratory
symptoms to the severity of airway obstruction as measured by pulmonary function tests [46].
In this regard, recording respiratory symptoms, such as CAS, has been reported to contribute
to improving the interpretation of spirometry in asthma [2]. Indeed, pioneering studies pro-
vided valuable measurements of wheezing for the assessment of certain obstructive pulmonary
diseases [48, 49], and showed that the combination of spirometry and RS analysis increases the
sensitivity of detection of pulmonary diseases [16].
Hence, in this study, we aimed to assess BDR in terms of acoustic parameters, which may
not necessarily coincide with BDR assessed by spirometry, but the combination of the two
techniques improves the assessment of BDR in asthma patients.
Analysis of CAS features
Using the Hilbert spectrum allowed CAS to be more accurately characterized with regard to D,
FMean, and I than using spectrogram, which has been the most widely used technique for CAS
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analysis, as we previously described [34]. These CAS features highly depend on the airway
diameter and the airway wall thickness, stiffness, elastance, and longitudinal tension [32]. In
this study, we also aimed to analyze CAS features, since they could help to better characterize
and distinguish between patients with different BDR. In particular, we analyzed CAS features
in asthma patients who had an appreciable response in the number of CAS, including the 5
BDR+ patients, the 6 BDR- patients with a high response, and the 4 BDR- patients with a
medium response (Fig 9).
Normality of the FMean, D, and I of CAS from each group was tested using a Lilliefors test.
Since not all CAS features had a normal distribution, non-parametric statistical tests were used
to analyze the differences in CAS features between groups.
Differences in the FMean, D, and I of CAS at baseline were analyzed between the three
groups using a Kruskal-Wallis test and multiple post hoc comparisons with the Bonferroni
adjustment. Significant differences (p<0.05) were found for the FMean, with BDR- patients
Fig 9. Population CAS features. Change in the number of CAS (nΔCASGlob) (A). Pink area = low response (L1),
purple area = medium response (L2), blue area = high response (L3). Boxplot distributions of the mean frequency
(FMean) (B), duration (D) (C), and intensity (I) (D) of CAS at baseline (GlobPre-BD) from BDR+ patients (79 CAS
components from 5 patients), BDR- patients with a high response (147 CAS components from 6 patients), and
BDR- patients with a medium response (59 CAS components from 4 patients). CAS features after bronchodilator
administration (GlobPost-BD) are also shown for the BDR- L2 group, since these patients still had an appreciable
number of CAS after bronchodilator (27 CAS components from 4 patients). Circles within boxes = medians,
boxes = interquartile ranges, whiskers = 1.5*interquartile ranges. Significant differences (p<0.05) are indicated
with an asterisk.
doi:10.1371/journal.pone.0171455.g009
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having lower values than BDR+ patients, and BDR- L2 patients having lower values than BDR-
L3 patients. Several previous studies reported that the mean frequency of CAS decreased after
bronchodilator administration, revealing that CAS containing higher frequencies are associ-
ated to a higher degree of airway obstruction [13, 20, 29, 31]. It has also been reported that the
pitch of CAS increases with narrower airways, thinner airway walls, or stiffer airway walls [32].
Accordingly, given that airway obstruction was higher (lower FEV1 and lower FEV1/FVC) in
BDR+ patients than in BDR- patients (see Table 1), the FMean of BDR+ patients was higher
than that of BDR- patients.
Differences in FMean, D, and I between CAS at baseline and CAS after bronchodilator
administration were analyzed for the BDR- patients with medium response (BDR- L2), who
still had an appreciable number of CAS after bronchodilation. In this case, a Wilcoxon rank
sum test was used to analyze the difference in each CAS feature. We found significant differ-
ences (p<0.05) in D and I, which were lower after bronchodilation, as reported in previous
studies [13, 20, 29, 31]. Bronchodilation reduces the resistance in the airways, which increases
the minimum critical flow necessary to generate CAS, reduces the oscillation of airway walls
and, as a result, reduces the D and I of CAS.
Beyond the aforementioned statistical significance of the results, CAS features had high var-
iability in all groups. The differences in CAS features between groups were not strong enough
to draw relevant clinical conclusions, which would require a larger population of asthma
patients. In any case, it seems that the potential of CAS feature analysis for assessing BDR in
terms of acoustic parameters is lower than that of the analysis of the number of CAS.
Conclusions
This study proposes an innovative, non-invasive, and thorough approach to CAS analysis for
assessing BDR. It has been shown that analyzing CAS provides quantitative information that
allows the BDR of asthma patients to be assessed in terms of acoustic parameters, beyond
those provided by spirometry. Previous attempts to analyze the relationship between BDR and
the presence of CAS were limited due to certain methodology issues that have been addressed
and overcome in this study. It is noteworthy that we trained and validated a high performance
classifier to distinguish CAS from other sounds. This classifier makes our approach to CAS
analysis more robust with respect to background noises in the clinical environment, reduces
CAS overestimation, and provides a novel tool for assessing patients with obstructive pulmo-
nary diseases in pulmonary function testing laboratories.
The multichannel analysis of CAS allows us to quantify changes in airway obstruction that
would not be detected by spirometry. Indeed, we were able to detect appreciable changes in
the number of CAS after bronchodilator administration in 10 of the 13 BDR- patients included
in this study, revealing some degree of change in airway obstruction. Therefore, together with
spirometry, which is a well-established and standard methodology for BDR assessment, the
analysis of CAS contributes to improving the stratification of BDR in asthma patients.
Limitations of the study
The study subjects were within a wide range of airway obstruction levels and BDR, thus
enabling the proposed approach to reveal its potential for improving the stratification of BDR
levels, particularly among patients with negative BDR. In this regard, we think that the pro-
posed categorization for the response in the number of CAS is reasonable and could be appli-
cable to a large population. Nevertheless, the promising results should be corroborated using a
larger number of asthma patients.
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Regarding CAS features, the differences between pure low-pitched wheezes and rhonchus,
or between stridor and high-pitched wheezes are still unclear, as reported in [10]. Therefore,
further studies should address in detail the characterization of different types of CAS. A better
understanding of the different types of CAS would help us to improve our acoustic component
segmentation and characterization algorithm which, in turn, would contribute to improving
the accuracy of our acoustic component classifier.
A key aspect of the proposed methodology is that CAS are not present in all asthma patients
and not all CAS are related to asthma. However, when present, CAS are an unequivocal sign of
airway obstruction. Accordingly, this approach to CAS analysis is proposed not as a unique
technique for assessing BDR, but as a high-sensitive tool for providing useful complementary,
objective, and quantitative information about BDR in patients exhibiting CAS, in a simple and
non-invasive way. Together with spirometry, this technique has a direct clinical application for
improving the stratification of BDR levels and the management of patients with obstructive
pulmonary diseases.
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